{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:50:34Z","timestamp":1792839034214,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jhep.2015.07.007","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T13:17:53Z","timestamp":1437398273000},"page":"1133-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients"],"prefix":"10.1016","volume":"63","author":[{"given":"Peter","family":"Jepsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Kragh","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Vilstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.07.007_b0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/1756-0500-5-509","article-title":"The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia \u2013 A historical cohort study","volume":"5","author":"Jepsen","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jhep.2015.07.007_b0010","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1478-3231.2007.01562.x","article-title":"Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis","volume":"27","author":"Kalaitzakis","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.07.007_b0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/1753-0407.12067","article-title":"Diabetes mellitus and decompensated cirrhosis: risk of hepatic encephalopathy in different age groups","volume":"5","author":"Butt","year":"2013","journal-title":"J Diabetes"},{"key":"10.1016\/j.jhep.2015.07.007_b0020","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1572-0241.2006.00649.x","article-title":"Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis","volume":"101","author":"Sigal","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.07.007_b0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000343458","article-title":"Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus","volume":"87","author":"Gundling","year":"2013","journal-title":"Digestion"},{"key":"10.1016\/j.jhep.2015.07.007_b0030","first-page":"119","article-title":"Prognostic significance of diabetes in patients with cirrhosis","volume":"20","author":"Bianchi","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.07.007_b0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11011-012-9354-2","article-title":"Role of diabetes mellitus on hepatic encephalopathy","volume":"28","author":"Ampuero","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2015.07.007_b0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.dld.2007.01.024","article-title":"Video-capsule endoscopy gastric and small bowel transit time and completeness of the examination in patients with diabetes mellitus","volume":"39","author":"Triantafyllou","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2015.07.007_b0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.07.007_b0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/17474124.2014.858598","article-title":"Recent insights into the pathogenesis of hepatic encephalopathy and treatments","volume":"8","author":"Sturgeon","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.07.007_b0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11011-013-9384-4","article-title":"Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development","volume":"28","author":"Watson","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2015.07.007_b0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2011-300157","article-title":"Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.07.007_b0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.07.007_b0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multi-state models and competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.07.007_b0075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.0006-341X.2002.00792.x","article-title":"Estimation of integrated transition hazards and stage occupation probabilities for non-Markov systems under dependent censoring","volume":"58","author":"Datta","year":"2002","journal-title":"Biometrics"},{"key":"10.1016\/j.jhep.2015.07.007_b0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.gastro.2013.09.019","article-title":"Development and validation of a comorbidity scoring system for patients with cirrhosis","volume":"146","author":"Jepsen","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.07.007_b0085","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.07.007_b0090","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10654-012-9739-x","article-title":"Mortality among participants and non-participants in a prospective cohort study","volume":"27","author":"Larsen","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jhep.2015.07.007_b0095","doi-asserted-by":"crossref","first-page":"e49279","DOI":"10.1371\/journal.pone.0049279","article-title":"Metformin inhibits glutaminase activity and protects against hepatic encephalopathy","volume":"7","author":"Ampuero","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.07.007_b0100","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/hep.23216","article-title":"Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.07.007_b0105","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hep.21404","article-title":"Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies","volume":"44","author":"S\u00f8rensen","year":"2006","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815004705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815004705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T22:55:56Z","timestamp":1717973756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815004705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0168827815004705"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.07.007","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}